stockportfolio.pro
Abbott Laboratories P/E Ratio 2007–2025
Abbott Laboratories (ABT) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +4.2%/yr over 18 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 33.30 | +131.8% |
| FY 2024 | 14.37 | -55.3% |
| FY 2023 | 32.12 | +22.7% |
| FY 2022 | 26.19 | -20.1% |
| FY 2021 | 32.77 | -17.2% |
| FY 2020 | 39.56 | +5.5% |
| FY 2019 | 37.50 | -21.2% |
| FY 2018 | 47.58 | -73.8% |
| FY 2017 | 181.59 | +429.3% |
| FY 2016 | 34.31 | +172.4% |
| FY 2015 | 12.60 | -48.0% |
| FY 2014 | 24.23 | +30.6% |
| FY 2013 | 18.56 | +36.6% |
| FY 2012 | 13.59 | -2.7% |
| FY 2011 | 13.96 | +19.8% |
| FY 2010 | 11.66 | +14.4% |
| FY 2009 | 10.20 | -11.6% |
| FY 2008 | 11.53 | -27.8% |
| FY 2007 | 15.97 | — |
Source: Abbott Laboratories SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Abbott Laboratories
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAbbott Laboratories — frequently asked questions
What is Abbott Laboratories's price-to-earnings ratio?
Abbott Laboratories (ABT) reported price-to-earnings ratio of 33.30 for fiscal year 2025, per its SEC filings.
How has Abbott Laboratories's price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, ABT's price-to-earnings ratio grew at roughly 4.2% per year (compound annual rate), from 15.97 to 33.30.
Where does this data come from?
Figures are computed from Abbott Laboratories's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.